Cargando…
The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia
BACKGROUND: Establishing preclinical models is essential for novel drug discovery in schizophrenia. Most existing models are characterized by abnormalities in behavioral readouts, which are informative, but do not necessarily translate to the symptoms of the human disease. Therefore, there is a nece...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359223/ https://www.ncbi.nlm.nih.gov/pubmed/22420779 http://dx.doi.org/10.1186/1756-0500-5-146 |